Provided by Tiger Trade Technology Pte. Ltd.

Angion Biomedica Corp.

10.00
0.0000
Volume:- -
Turnover:225.20K
Market Cap:30.11M
PE:-1.03
High:10.00
Open:10.00
Low:10.00
Close:10.00
52wk High:20.40
52wk Low:4.60
Shares:3.01M
Float Shares:2.09M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6757
EPS(LYR):-12.9181
ROE:-54.47%
ROA:-20.89%
PB:0.76
PE(LYR):-0.77

Loading ...

Company Profile

Company Name:
Angion Biomedica Corp.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States. The company develops ANG-3070, an oral tyrosine kinase receptor inhibitor for fibrotic diseases in kidney and lung. It also develops ROCK2 inhibitors for fibrotic diseases; CYP11B2, an inhibitor program for aldosterone-related diseases, including resistant hypertension, congestive heart failure, renal fibrosis, and hyperaldosteronism; and CYP26 for the degradation of retinoic acid. Angion Biomedica Corp. was incorporated in 1998 and is based in Uniondale, New York.